Trinity Biotech reported $-17.48M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Bayer EUR 2.76B 6.52B Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
EDAP TMS EUR -5.01M 586K Sep/2025
J&J USD 5.53B 299M Jun/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Siemens EUR 2.03B 3M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Tosoh JPY 16.99B 266M Mar/2026
Trinity Biotech USD -17.48M 12.34M Dec/2025
Veracyte USD 28.71M 12.44M Mar/2026